Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin embonate 6-month SC in advanced prostate cancer
NCT01656161Phase 3Completed
- Sponsor
- Debiopharm
- Start
- Jul 2012
- Primary completion
- Aug 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in prostate cancer (PCa), sponsored by Debiopharm. Started Jul 2012; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01656161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01656161.